Pressure BioSciences, Inc. (PBIO)
OTCMKTS: PBIO · Delayed Price · USD
0.225
+0.004 (1.64%)
May 6, 2024, 10:42 AM EDT - Market open
Pressure BioSciences Revenue
Pressure BioSciences had revenue of $2.27M in the twelve months ending September 30, 2023, with 58.11% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $413.01K with 186.75% year-over-year growth. In the year 2022, Pressure BioSciences had annual revenue of $1.73M, a decrease of -13.63%.
Revenue (ttm)
$2.27M
Revenue Growth
+58.11%
P/S Ratio
2.27
Revenue / Employee
$142,037
Employees
16
Market Cap
5.15M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 1.73M | -273.02K | -13.63% |
Dec 31, 2021 | 2.00M | 781.77K | 64.05% |
Dec 31, 2020 | 1.22M | -589.40K | -32.56% |
Dec 31, 2019 | 1.81M | -647.88K | -26.36% |
Dec 31, 2018 | 2.46M | 217.37K | 9.70% |
Dec 31, 2017 | 2.24M | 264.01K | 13.36% |
Dec 31, 2016 | 1.98M | 178.80K | 9.95% |
Dec 31, 2015 | 1.80M | 422.95K | 30.77% |
Dec 31, 2014 | 1.37M | -128.54K | -8.55% |
Dec 31, 2013 | 1.50M | 265.07K | 21.41% |
Dec 31, 2012 | 1.24M | 250.49K | 25.36% |
Dec 31, 2011 | 987.73K | -352.30K | -26.29% |
Dec 31, 2010 | 1.34M | 95.12K | 7.64% |
Dec 31, 2009 | 1.24M | 392.65K | 46.07% |
Dec 31, 2008 | 852.26K | 206.39K | 31.96% |
Dec 31, 2007 | 645.87K | 435.58K | 207.13% |
Dec 31, 2006 | 210.29K | 104.76K | 99.28% |
Dec 31, 2005 | 105.53K | -307.09K | -74.43% |
Dec 31, 2004 | 412.62K | -22.88M | -98.23% |
Dec 31, 2003 | 23.30M | 531.05K | 2.33% |
Dec 31, 2002 | 22.76M | 938.53K | 4.30% |
Dec 31, 2001 | 21.83M | 2.36M | 12.10% |
Dec 31, 2000 | 19.47M | -9.83M | -33.55% |
Dec 31, 1999 | 29.30M | 3.20M | 12.26% |
Dec 31, 1998 | 26.10M | 3.80M | 17.04% |
Dec 31, 1997 | 22.30M | 6.80M | 43.87% |
Dec 31, 1996 | 15.50M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.33B |
PBIO News
- 4 weeks ago - Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection” - GlobeNewsWire
- 2 months ago - Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc. - GlobeNewsWire
- 2 months ago - Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing - GlobeNewsWire
- 3 months ago - Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness - GlobeNewsWire
- 3 months ago - Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds - GlobeNewsWire
- 3 months ago - Pressure BioSciences Announces Closing of Uncle Bud's Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales - GlobeNewsWire
- 3 months ago - Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order - GlobeNewsWire
- 3 months ago - Pressure BioSciences' New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January - GlobeNewsWire